title: Gastrointestinal symptoms after pelvic radiotherapy: a national survey of gastroenterologists.
abstract: OBJECTIVE
  Seventeen thousand patients receive treatment with radical pelvic radiotherapy annually in the UK. Up to 50% develop significant gastrointestinal symptoms. The National Cancer Survivorship Initiative has identified access to specialist medical care for those with complications after cancer as one of their four key needs. We aimed to determine the current practice of British gastroenterologists with regards to chronic gastrointestinal symptoms after pelvic radiotherapy.
  
  
  METHODS
  A questionnaire was developed and sent up to a maximum of five times to all UK consultant gastroenterologists.
  
  
  RESULTS
  Eight hundred sixty-six gastroenterologists were approached and 165 (20%) responded. Sixty-one percent saw one to four patients annually with bowel symptoms after radiotherapy. Eighteen percent rate the current treatments as effective "often" or "most of the time". Forty-seven percent of gastroenterologists consider themselves "confident with basic cases", with 11% "confident in all cases". Fifty-nine percent thinks a gastroenterologist with a specialist interest should manage these patients. Although only 29% thinks a specific service is required for these patients, 34% rates the current service as inadequate. The ideal service was considered to be gastroenterology-led, multidisciplinary and regional. Low referral rates, poor evidence-base and poor funding are cited as reasons for the current patchy services.
  
  
  CONCLUSIONS
  The low response rate contrasts with that from a parallel survey of clinical oncologists. This may reflect the opinion that radiation-induced bowel toxicity is not a significant issue, which may be because only a small proportion of patients are referred to gastroenterologists. The development of new, evidence-based gastroenterology-led services is considered the optimal way to meet the needs of these patients.
authors.affiliation: Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK. caroline.henson@christie.nhs.uk
authors.forename: C C
authors.initials: CC
authors.lastname: Henson
authors.forename: S E
authors.initials: SE
authors.lastname: Davidson
authors.forename: A
authors.initials: A
authors.lastname: Lalji
authors.forename: R P
authors.initials: RP
authors.lastname: Symonds
authors.forename: R
authors.initials: R
authors.lastname: Swindell
authors.forename: H J N
authors.initials: HJ
authors.lastname: Andreyev
mesh_terms: D005762:Gastroenterology; D005767:Gastrointestinal Diseases / Q000453:epidemiology / Q000209:etiology*; D019538:Health Care Surveys; D006801:Humans; D010386:Pelvic Neoplasms / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000150:complications*; D011795:Surveys and Questionnaires; D006113:United Kingdom / Q000453:epidemiology
references.citation: Gynecol Oncol. 2005 Feb;96(2):490-5
references.pmid: 15661240
references.citation: Lancet. 2001 Sep 8;358(9284):781-6
references.pmid: 11564482
references.citation: Eur J Cancer Care (Engl). 1995 Dec;4(4):158-65
references.pmid: 8548137
references.citation: J R Soc Med. 1983 Jun;76(6):463-6
references.pmid: 6864719
references.citation: Clin Radiol. 1985 May;36(3):275-8
references.pmid: 4064510
references.citation: Br J Cancer. 2009 Aug 4;101(3):541-7
references.pmid: 19568236
references.citation: Clin Oncol (R Coll Radiol). 2005 Sep;17(6):469-77
references.pmid: 16149292
references.citation: Gut. 1991 Oct;32(10):1180-7
references.pmid: 1955174
references.citation: Clin Oncol (R Coll Radiol). 2010 Sep;22(7):590-601
references.pmid: 20594810
references.citation: Lancet. 2000 Apr 22;355(9213):1404-11
references.pmid: 10791524
references.citation: South Med J. 1987 Oct;80(10):1259-61
references.pmid: 3660042
references.citation: Lancet Oncol. 2007 Nov;8(11):1007-17
references.pmid: 17976611
references.citation: Clin Oncol (R Coll Radiol). 2011 Oct;23(8):552-7
references.pmid: 21550216
references.citation: Acta Obstet Gynecol Scand. 2002 May;81(5):443-50
references.pmid: 12027819
references.citation: Ann Surg. 1969 Sep;170(3):369-84
references.pmid: 4979653
references.citation: Curr Opin Support Palliat Care. 2009 Mar;3(1):36-40
references.pmid: 19262387
references.citation: Postgrad Med J. 1992 Apr;68(798):272-6
references.pmid: 1409191
references.citation: Croat Med J. 2000 Sep;41(3):314-8
references.pmid: 10962052
references.citation: Lancet Oncol. 2010 Apr;11(4):310-2
references.pmid: 20149738
references.citation: Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1464-71
references.pmid: 15927411
references.citation: Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):777-87
references.pmid: 15465194
references.citation: Dig Dis Sci. 1991 Jan;36(1):103-7
references.pmid: 1670631
references.citation: Lancet. 1997 Aug 23;350(9077):535-40
references.pmid: 9284774
references.citation: Radiother Oncol. 1999 Apr;51(1):43-53
references.pmid: 10386716
references.citation: Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1218-21
references.pmid: 17689027
references.citation: Am J Clin Nutr. 1985 Jan;41(1):85-91
references.pmid: 3917601
references.citation: Clin Oncol (R Coll Radiol). 2004 Apr;16(2):95-104
references.pmid: 15074730
references.citation: Clin Oncol (R Coll Radiol). 2011 Oct;23(8):538-51
references.pmid: 21530194